ArticlePloS one

Correction: An Anti-Parkinson's Disease Drug via Targeting Adenosine A2A Receptor Enhances Amyloid-β Generation and γ-Secretase Activity.

PLOS ONE StaffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.